Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Neurochem. 2018 Sep 11;147(2):222–239. doi: 10.1111/jnc.14555

Fig. 4.

Fig. 4

VU0409551 treatment increased the expression of genes important for synaptic plasticity. Graphs show brain-derived neurotrophic factor (BDNF) mRNA levels in the hippocampus (a) and striatum (b), Arc/Arg3.1 mRNA levels in the hippocampus (c) and striatum (d), syntaxin 1A mRNA levels in the hippocampus (e) and striatum (f) and post-synaptic density-95 (PSD-95) mRNA levels in the hippocampus (g) and striatum (h) of wild-type (WT) and BACHD mice, treated with either vehicle or VU0409551. mRNA levels were assessed by RT-qPCR, which was performed in triplicate and normalized to actin mRNA levels. Data represent the means ± SEM. Number of mice: n = 6. indicates significant difference (p < 0.05).